Records / Price observations

Substantially all assets of 23andMe Holding Co. (direct-to-consumer genetic testing business, about 13 million customers, genetic and other personal data, medical research programme), sold to TTAM Research Institute in Chapter 11 under section 363. The price is for the whole business, not the data alone.

$305 million per sale of substantially all assets of one company (whole-business bundle)

Dated 27 Jun 2025Source checked 19 Oct 2026Page out of reach at the last check, 21 Oct 2026Basis: docket

In the source's own words
“The Debtors conducted this final round on June 13, 2025 (Walper Decl. ¶ 18). Regeneron did not submit an additional bid (Id.). The Special Committee thus selected TTAM’s $305 million bid as the winning bid (Walper Decl. ¶ 19).”
Also read from the same source

All 10 records from this source

What it is about
Figures it counts in
Substantially all assets of 23andMe Holding Co. (direct-to-consumer genetic testing… | AIData.Broker